MiNK Therapeutics, Inc. ( INKT) - Key Metrics
INKT Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.62 | -$414.62 | -$414.62 |
| 2026Q1 | $0 | -$0.57 | -$0.36 | -$0.36 |
| 2025Q4 | $0 | -$0.61 | -$0.49 | -$0.49 |
| 2025Q3 | $0 | -$0.65 | -$0.21 | -$0.21 |
| 2025Q2 | $0 | -$1.06 | -$0.39 | -$0.39 |
INKT Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -4.71 |
| 2026Q1 | 0% | -4.62 |
| 2025Q4 | 0% | -5.07 |
| 2025Q3 | 0% | -5.38 |
| 2025Q2 | 0% | -1.74 |
INKT
Price: $12
52 week price:
Earnings Per Share: -2.80 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 4128
Market Capitalization: 57.5 million